Please login to the form below

Not currently logged in
Email:
Password:

innovation in life sciences

This page shows the latest innovation in life sciences news and features for those working in and with pharma, biotech and healthcare.

Orphan drugs from Biogen and Amicus win UK Prix Galien

Orphan drugs from Biogen and Amicus win UK Prix Galien

Rawlins. “The 2018 Awards yet again confirmed the depth and diversity of innovation in UK life sciences. ... That’s the essence of UK Prix Galien. And it once again confirms that UK life sciences are as strong as ever.”.

Latest news

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • The science of the deal The science of the deal

    Business development is more like child-raising than you might think. When one looks for megatrends in the life sciences industry, externally sourced innovation stands out. ... As we begin to conclude our research, we are increasingly comparing

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    High world rankings. Indeed, despite its small size, Switzerland holds a high place in innovation rankings, with a strong life sciences sector based around three hubs: Zug/ Zurich, Basel and ... Ranked among the ‘50 Smartest Companies’ in the world

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    8. DR SAM ROBERTS. Innovation translator. The UK life sciences sector has always lacked a single leader who could bring the NHS and industry together to work on promoting research and ... She was made NHS England’s director for innovation and life

  • In conversation with Pfizer’s Erik Nordkamp In conversation with Pfizer’s Erik Nordkamp

    The Life Sciences Industrial Strategy could increase the speed with which new medicines and vaccines are made available across the UK, if implemented in full and with the involvement and commitment ... We have also joined forces with Swansea University

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    The appraisal system in the UK needs to reflect that specific genes and pathways underlying genetic diseases seldom respond to traditional pharmaceutical approaches and so precision medicine requires risk-taking innovation. ... The Life Sciences

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • CBI, UBM Life Sciences

    Powering thought leadership through leaderships, partnerships and innovation in life sciences. ... CBI, UBM Life Sciences.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics